We can change the natural history of type 2 diabetes

Lawrence S Phillips1, Robert E Ratner2, John B Buse3

  • 1Atlanta VA Medical Center, Decatur, GA Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA lawrence.phillips@emory.edu.

Diabetes Care
|September 25, 2014
PubMed

Insights

Early detection and effective treatment of prediabetes and early diabetes can prevent or delay hyperglycemia and complications. Interventions show lasting benefits, suggesting proactive management can alter the disease

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Preventive Medicine

Background:

  • Diabetes mellitus natural history involves a significant preclinical phase.
  • Current diagnostic approaches often identify diabetes after substantial hyperglycemia and potential complications have developed.
  • Early intervention in prediabetes and early diabetes is crucial for altering disease trajectory.

Purpose of the Study:

  • To evaluate the impact of early detection and effective management of prediabetes and early diabetes.
  • To determine if interventions can prevent or delay the progression of hyperglycemia and associated complications.
  • To assess the long-term effects of interventions after their withdrawal.

Main Methods:

  • Review of evidence from clinical trials involving lifestyle changes and/or glucose-lowering medications.
  • Analysis of cumulative diabetes development in treated versus control groups.
  • Examination of the association between transient normal glucose levels and subsequent diabetes incidence.

Main Results:

  • Interventions like lifestyle changes and medications reduced progression from prediabetes to diabetes.
  • Previously treated groups showed less cumulative diabetes development even after intervention withdrawal.
  • Transient achievement of normal glucose levels significantly reduced subsequent diabetes development.

Conclusions:

  • Routine screening for prediabetes and early diabetes is recommended.
  • Management strategies should aim for glucose levels as close to normal as possible without causing hypoglycemia.
  • A randomized controlled trial is proposed to further test these findings.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
42
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
26
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
9